# FDA recall D-0716-2022

> **Teligent Pharma, Inc.** · Class II · drug recall initiated 2022-02-07.

## Product

Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-053-66.

## Reason for recall

Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds.

## Distribution

Nationwide in the USA.

## Key facts

- **Recall number:** D-0716-2022
- **Recalling firm:** Teligent Pharma, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-02-07
- **Report date:** 2022-02-23
- **Termination date:** 2024-05-09

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Buena, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0716-2022

## Citation

> AI Analytics. FDA recall D-0716-2022. Retrieved 2026-06-15 from https://api.ai-analytics.org/recall/D-0716-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*